Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study.
Saved in:
| Title: | Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study. |
|---|---|
| Authors: | Stirrup O; Institute for Global Health, University College London, London, United Kingdom., Blackstone J; The Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Mapp F; Institute for Global Health, University College London, London, United Kingdom., MacNeil A; The Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Panca M; The Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Holmes A; Imperial College Healthcare NHS Trust, London, United Kingdom., Machin N; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Shin GY; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Mahungu T; Royal Free London NHS Foundation Trust, London, United Kingdom., Saeed K; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Saluja T; Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom., Taha Y; Department of Virology and Infectious Diseases, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Mahida N; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Pope C; St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Chawla A; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom., Cutino-Moguel MT; Barts Health NHS Trust, London, United Kingdom., Tamuri A; Research Computing, University College London, London, United Kingdom., Williams R; Department of Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Darby A; Centre for Genomic Research, University of Liverpool, Liverpool, United Kingdom., Robertson DL; MRC-University of Glasgow Centre For Virus Research, University of Glasgow, Glasgow, United Kingdom., Flaviani F; Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom., Nastouli E; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Robson S; Centre for Enzyme Innovation and School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom., Smith D; Department of Applied Sciences, Northumbria University, Newcastle-upon-Tyne, United Kingdom., Loose M; School of Life Sciences, University of Nottingham, Nottingham, United Kingdom., Laing K; Institute for Infection and Immunity, St George's University of London, London, United Kingdom., Monahan I; Institute for Infection and Immunity, St George's University of London, London, United Kingdom., Kele B; Barts Health NHS Trust, London, United Kingdom., Haldenby S; Centre for Genomic Research, University of Liverpool, Liverpool, United Kingdom., George R; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Bashton M; The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Northumbria University, Newcastle, United Kingdom., Witney AA; Institute for Infection and Immunity, St George's University of London, London, United Kingdom., Byott M; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Coll F; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom., Chapman M; Health Data Research UK Cambridge Hub, Cambridge, United Kingdom., Peacock SJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Hughes J; MRC-University of Glasgow Centre For Virus Research, University of Glasgow, Glasgow, United Kingdom., Nebbia G; Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom., Partridge DG; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Parker M; Sheffield Bioinformatics Core, University of Sheffield, Sheffield, United Kingdom., Price JR; Imperial College Healthcare NHS Trust, London, United Kingdom., Peters C; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Roy S; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Snell LB; Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom., de Silva TI; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Thomson E; MRC-University of Glasgow Centre For Virus Research, University of Glasgow, Glasgow, United Kingdom., Flowers P; School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom., Copas A; Institute for Global Health, University College London, London, United Kingdom., Breuer J; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. |
| Corporate Authors: | COG-UK HOCI Investigators, COVID-19 Genomics UK (COG-UK) consortium |
| Source: | ELife [Elife] 2022 Sep 13; Vol. 11. Date of Electronic Publication: 2022 Sep 13. |
| Publication Type: | Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
